Demographic and Clinical Features of Dengue Fever in Pakistan from 2003–2007: A Retrospective Cross-Sectional Study by Khan, Erum et al.
Demographic and Clinical Features of Dengue Fever in
Pakistan from 2003–2007: A Retrospective Cross-
Sectional Study
Erum Khan
1*, Mehreen Kisat
2, Nabil Khan
1, Amna Nasir
1, Salma Ayub
1, Rumina Hasan
1
1Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi, Pakistan, 2Medical College, Aga Khan University Hospital, Karachi, Pakistan
Abstract
Background: Demographic features of dengue fever have changed tremendously in Pakistan over the past two decades.
Small scale studies from all over the country have reported different aspects of individual outbreaks during this time.
However, there is scarcity of data looking at the overall trend of dengue virus infection in the country. In this study, we
examined annual trends, seasonality, and clinical features of dengue fever in the Pakistani population.
Methods: Demographic information and dengue IgM status of all patients tested for dengue IgM antibody at Aga Khan
University Hospital from January 2003 to December 2007 were analyzed to look for trends of IgM-positive cases in Pakistan.
In addition, clinical and biochemical parameters were abstracted retrospectively from medical records of all patients
hospitalized with IgM-proven dengue fever between January 2006 and December 2007. These patients were categorized
into dengue fever and dengue hemorrhagic fever according to the WHO severity grading scale.
Results: Out of a total of 15040 patients (63.2% male and 36.8% female), 3952 (26.3%) tested positive for dengue IgM
antibody. 209 IgM proven dengue patients were hospitalized during the study period. During 2003, IgM positive cases were
seen only during the months of July-December. In contrast, such cases were detected throughout the year from the 2004–
2007. The median age of IgM positive patients decreased every year from 32.0 years in 2003 to 24.0 years in 2007 (p,0.001).
Among hospitalized patients, nausea was the most common presenting feature found in 124/209 (59.3%) patients. Children
presented with a higher median body temperature than adults (p=0.010). In addition, neutropenia was seen more
commonly in children while raised serum ALT levels were seen more commonly in adults (both p=0.006). While a low total
white cell count was more common in patients with dengue fever as compared to Dengue Hemorrhagic Fever (p=0.020),
neutropenia (p=0.019), monocytosis (p=0.001) and raised serum ALT level (p=0.005) were observed more commonly in
the latter group.
Conclusions: Dengue virus is now endemic in Pakistan, circulating throughout the year with a peak incidence in the post
monsoon period. Median age of dengue patients has decreased and younger patients may be more susceptible. Total and
differential leukocyte counts may help identify patients at risk of hemorrhage.
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Introduction
Dengue Virus (DV) is an enveloped, single-stranded, positive
RNA virus and a member of the family Flaviviridae, genus flavivirus.
There are four antigenically related but distinct serologic subtypes;
DV-1, DV-2, DV-3 and DV-4. An estimated 50-100 million cases
of Dengue Fever (DF) and about 250,000–500,000 cases of
Dengue Hemorrhagic Fever (DHF) occur every year [1]. In South
East Asia, the average number of cases of DHF per year has
increased from 10,000 in the 1950s to over 200,000 in the 1990s.
Thus, dengue virus remains a major cause of morbidity and
mortality in tropical areas [2].
Epidemic dengue fever was common in Asia and Pacific
throughout the twentieth century [3]. Dengue virus made its route
geographically into Asia through South Asian countries [4]. In
Asia, the first outbreak of DHF began in the 1950s in the
Philippines and Thailand. However, in the next 20 years, the
disease spread throughout South East Asia and by the mid 1970s,
DHF was the leading cause of hospitalization and death among
children in this region. Thereafter in the 1980s and 1990s, dengue
transmission intensified with regular epidemics every 3–5 years in
hyperendemic areas [5].
In Pakistan, the first confirmed outbreak was due to serotype
DV-2 reported in 1994 by Aga Khan University Hospital
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be reported from different parts of the country. Akram et al
reported the presence of DV-1 and DV-2 in the sera of
children with undifferentiated fever [7]. In addition, Paul et al
reported in 1998 that an outbreak of dengue fever in the
Balochistan province was due to co-circulation of DV-1 and
DV-2 [8].
During September to December 2005, three major hospitals
in Karachi had a sudden increase in the number of patients
with DHF [9]. Genotyping of selected samples from the early
part of the outbreak revealed the presence of DV-3. This
epidemic was probably a consequence of the introduction of
DV-3 in a population with prior sensitization to DV-1 and
DV-2 resulting in severe disease. Thereafter, Pakistan experi-
enced its largest and most severe outbreak of DHF in 2006 and
DV-2 and DV-3 were identified as the predominant serotypes
[10].
The demographic features of DF and DHF have changed
tremendously in South East Asia and Pakistan over the past
two decades. Small scale studies from all over the country have
reported different aspects of major individual outbreaks during
this time. However, there is scarcity of data looking at the
overall trend of DV infection in the country. We maintained a
data and serum bank of all the patients tested for the presence
of dengue IgM antibodies from 2003–2007. In the current
study, we have looked at annual trends and demographics of
dengue infections in the Pakistani population over five years.
In addition, we have also evaluated clinical and laboratory
features of patients hospitalized with dengue fever during
2006–2007.
Methods
Ethics Statement
The study protocol was approved by Ethical Review Committee
at Aga Khan University Hospital. No interventions or any sort of
study-related patient interaction was involved. In addition, all data
was analyzed anonymously and hence, informed consent was not
required.
Location and sampling
AKUH is a 550-bed tertiary care hospital located in Karachi,
Pakistan. The clinical laboratory has a unique network of clinical
sample collection units spread through out the country. Samples
were received from 125 collection sites including the main hospital
site, 71 sites within Karachi and 44 sites in the rest of Pakistan.
Distribution of samples received and geographical location of sites
has been described in Figure 1. Demographic data from all
patients tested for dengue IgM antibody between January 2003
and December 2007 at AKUH was included in this study. In
addition, medical records of all patients with IgM proven dengue
who were hospitalized for treatment at AKUH from 2006–2007
was reviewed retrospectively for clinical and biochemical data.
Hospitalized patients were categorized into Dengue Fever,
Dengue Hemorrhagic Fever and Dengue Shock Syndrome
according to the World Health Organization (WHO) severity
grading scale [11].
Dengue IgM antibodies were detected using the Calbiotech Inc.
ELISA test system (Catalog No. DE051M). This is a commercial
Enzyme-Linked ImmunoSorbent Assay for detecting IgM anti-
bodies against dengue virus in human serum or plasma. Optical
Figure 1. Geographical distribution of cities with laboratory collection points in Pakistan. This map presents the geographical
distribution of cities with laboratory collection points from where samples used in this study were received. Colours denote the four provinces of
Pakistan as described in the legend. Aga Khan University Hospital (AKU, Karachi) was the study center.
doi:10.1371/journal.pone.0012505.g001
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600–650nm. Antibody Index was calculated using the OD value
and the cut-off value (Calibrator OD 6 Calibrator Factor).
Antibody index of .1.1 was considered positive for acute dengue
infection and those between 0.9 and 1.1 were included in
borderline positive category. Hence, samples with indexes below
0.9 were concluded as negative for dengue infection.
Data management and statistical analysis
The blood indices were initially measured on a continuous scale
and then categorized on the basis of clinically meaningful cutoffs.
Thrombocytopenia was defined as a platelet count ,150,000
cells/mm
3 blood. A hematocrit value .48% was considered
raised. Similarly, leucopenia was defined as a white cell count
,4000 cells/mm
3, neutropenia as neutrophils ,40%, lymphocy-
tosis as lymphocytes .45% and monocytosis as monocytes .10%.
Alanine aminotransferase (ALT) was considered raised if .55 and
.33 IU/L for males and females, respectively. Aspartate
aminotransferase (AST) was defined as raised if .46 and
.32 IU/L for males and females, respectively.
Statistical Package for Social Sciences (SPSS) version 15.0
(Chicago, IL) was used for data entry, processing and statistical
analysis at the end of the study period. Descriptive statistics were
calculated for all relevant variables. Since age and laboratory
measurements were not normally distributed (Shapiro-Wilk
p,0.05), median 6 interquartile range has been reported.
Differences between several groups of patients were evaluated
using Chi-square test or Fisher’s Exact test for categorical variables
and Mann-Whitney U test for continuous variables. Odds Ratios
(OR) were calculated to evaluate the relationship between two
categorical variables. P-values less than 0.05 were considered
significant.
Results
Demographic Findings
A total of 15040 serum samples were tested for dengue IgM
antibodies during the study period (2003–2007). This included
9500 males (63.2%) and 5540 females (36.8%). 11917 patients
(90.9%) were from Karachi while 1199 patients (9.1%) were from
other cities of Pakistan (Figure 1) The median age of the patients
was 24.0620.0 years. There were 11041 (73.6%) adults and 3955
(26.4%) children (aged less than equal to 15 years). The total
number of people tested for Dengue IgM increased progressively
until 2006 and then declined in 2007.
Of the 15040 patients tested, 3952 samples (26.3%) were
positive for Dengue IgM antibody. There was no significant
difference in seropositivity between samples collected within or
outside Karachi (p=0.221). The percentage of patients demon-
strating IgM seropositivity increased from 28.3% in 2003 to 35.9%
in 2004 and then decreased progressively from 2005 to 2007. The
trends observed in percentage of patients with dengue IgM
seropositivity have been illustrated quarter-wise in Figure 2.
During 2003, IgM positive cases were only observed in the months
of July - December. However, such cases were detected
throughout the year from 2004–2007. In addition, the highest
proportion of seropositivity was seen in the last three months of the
year from 2003–2006. However, in 2007, the highest proportion
of such cases was observed in the third quarter of the year.
61% (n=2403) of total patients who tested positive for Dengue
IgM during all five years were male. Although not statistically
significant, this gender distribution evolved from 2003 to 2007
such that the proportion of females amongst IgM positive cases
increased (p=0.253). On the whole, the odds of seropositivity over
all 5 years were higher in women than in men (95% CI OR: 1.07,
1.25; p,0.001).
The median age of the dengue patients has decreased over the
study period from 32.0 years in 2003 to 24.0 years in 2007
(p,0.001, d.f.=4, see Figure 3). While the highest proportion of
seropositivity was observed in patients aged 26–40 years in 2003
and 2004, this trend shifted to patients aged 11–25 years in 2005–
2007 (see Table 1). In addition, the median age of female dengue
patients was significantly lower than males (24.2 years compared
to 25.9 years respectively: p,0.001).
Clinical and Laboratory Findings
A total of 209 patients including 132 males (63.2%) and 77
females (36.8%) with a median age of 25617 years were
hospitalized at AKUH during the defined study period.
Figure 2. Quarterly distribution of the percentage of Dengue IgM positive cases by year. In 2003, Dengue IgM positive cases were only
observed to appear in the months of July- December. This trend changed from 2004–2007, when IgM positive cases were detected throughout the
year. Dengue IgM positive cases were most prevalent in the fourth quarter (October–December) from the years 2003 to 2006.
doi:10.1371/journal.pone.0012505.g002
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werenauseain124patients (59.3%), rash in76patients (36.4%) and
myalgia in 54 patients (25.8%) followed by hemorrhage in 38
patients (18.2%), diarrhea in 34 patients (16.3%), cough in 23
patients (11.0%) and headache in 23 patients (11.0%). Hemoglobin
levels less than 10 mg/dL were observed in 27/182 patients
(14.8%). Total leukocyte count was decreased in 75/186 patients
(40.3%). In the differential leukocyte count, 52/160 patients
(32.5%) had monocytosis,55/173 patients (31.8%) had neutropenia
and 41/171 patients (24.0%) had lymphocytosis. 158/199 patients
(79.4%) had thrombocytopenia at presentation. AST was raised in
93/106 patients (87.7%) and ALT was raised in 91/145 patients
(62.8%). Males had a higher hematocrit (41.566.8%) as compared
to females (36.866.2%) at the time of admission (p,0.001).
There were 81% (169/209) adults (31.9612.9 years) and 19%
(40/209) children (9.364.5 years) in this sample. Body tempera-
ture was significantly higher in children (38.062.0uC) as compared
to adults (37.661.0uC; p=0.010). Neutropenia was also seen more
commonly in children (p=0.006). ALT levels were raised in 83
out of 123 (64.5%) adults as compared to 8 out of 22 (36.4%)
children (p=0.006). However, no significant difference in AST
levels at presentation was seen.
Dengue fever was diagnosed in 161/206 patients (99 male, 62
female) and dengue hemorrhagic fever was diagnosed in 40/206
Figure 3. Median age of patients from 2003–2007. The median age of patients has decreased between the years 2003 and 2007.
doi:10.1371/journal.pone.0012505.g003
Table 1. Distribution of dengue IgM positive cases according to age groups from 2003–2007.
Number of patients in each age group(age in years) – n(%)
1
Year ,=2 3–10 11–25 26–40 41–55 56–70 .=71 Total
2003 0 (0.0) 0 (0.0) 7 (19.4) 21 (58.3) 5 (13.9) 2 (5.6) 1 (2.8) 36
2004 0 (0.0) 0 (0.0) 8 (34.8) 9 (39.1) 3 (13.0) 2 (8.7) 1 (4.3) 23
2005 0 (0.0) 4 (2.6) 83 (53.5) 43 (27.7) 18 (11.6) 7 (4.5) 0 (0.0) 155
2006 77 (2.4) 357 (10.9) 1475 (45.2) 944 (28.9) 306 (9.4) 98 (3.0) 9 (3.0) 3266
2007 9 (2.0) 63 (13.9) 202 (44.7) 116 (25.7) 47 (10.4) 13 (2.9) 2 (4.0) 452
Total 86 (2.2) 424 (10.8) 1775 (45.1) 1133 (28.8) 379 (9.6) 122 (3.1) 13 (3.0) 3932
1Percentage was expressed using total number of dengue IgM positive patients for each year as denominator.
doi:10.1371/journal.pone.0012505.t001
Dengue Fever in Pakistan
PLoS ONE | www.plosone.org 4 September 2010 | Volume 5 | Issue 9 | e12505patients (30 male, 10 female, p=0.077). 5/206 patients were
classified as Dengue Shock Syndrome and were excluded from
comparative analysis due to their statistically inadequate number.
Sociodemographic, clinical and laboratory features of these
patients with DF and DHF have been described in Table 2.
18.6% patients with dengue fever and 17.5% patients with dengue
hemorrhagic fever were below the age of 15 years.
31 out of 40 patients with DHF developed a rash as compared
to 44 out of 161 patients with DF (p,0.001). 36 out of 40 patients
with DHF had thrombocytopenia on presentation compared to
116 out of 151 patients with DF (p=0.047). Leukopenia was seen
more commonly in patients with DF as compared to DHF
(p=0.015). On the other hand, neutropenia and monocytosis were
seen more commonly in patients with DHF (p=0.019 and
p=0.001 respectively; see Figure 4). Median ALT levels were
significantly higher in patients with DHF as compared to the
patients with DF (p=0.011).
Discussion
Dengue virus presently threatens half of the world’s population
and is an important public health problem in many tropical
regions of the world [12]. In the last three decades, the
demographic and clinical features of dengue infections have
changed rapidly. Pakistan experienced the first major outbreak of
Dengue in 2004 and the serotype identified was DV-2 [6].
Thereafter, several studies from Pakistan and other endemic areas
reported DV-1 and DV-2 to be the predominant serotypes in
circulation [7,8]. This was followed by the introduction of DV-3 in
our population in 2005 resulting in another epidemic [9]. During
the most recent epidemic in 2006, the genotypes DV-2 and DV-3
were found to be prevalent in Pakistan [10].
The epidemics of dengue have been commonly associated with
the rainy season [13]. The peak incidence of dengue fever was
reported to occur from August to October in Pakistan [14].
Similarly, this study found the highest proportion of IgM positive
dengue patients in the last two quarters of 2006 and 2007, an
observation also shared by another South Asian study [15]. While
the first IgM positive cases were detected in the month of July in
2003 in our study, such cases were prevalent throughout the year
from 2004–2007. This is consistent with another recent study from
Hong Kong where dengue cases were reported all year round
[16]. Similarly, Tripathi et al reported that dengue transmission
occurred round the year in Lucknow region in India with peak
incidence in the post-monsoon season [17]. This trend may be
explained by the hyper-endemicity of the virus and the co-
circulation of all four serotypes. Factors responsible for mainte-
nance of dengue fever throughout the year need to be identified
and addressed in future studies.
There is conflicting data on the shift in median age of dengue
virus. Several studies from Asia using surveillance data report
increasing age of effected patients. In Indonesia, data from 1975 to
1984 showed an increase in incidence rates among young adults in
Jakarta as well as in the provincial areas [18]. In contrast, a
decrease in median age of patients affected with dengue from
2003–2007 was seen in this study. The most common age group
affected in the recent years was 11–25 years. A progressive
increase in the proportion of children affected with dengue was
also observed. Not a single child was affected in 2003 and 2004 but
number of children testing positive for dengue IgM increased
dramatically between 2005 and 2007. Since the DV-2 strain has
been circulating in the Pakistani population since 2004, the
observed shift in median age may be explained by adults acquiring
immunity due to earlier infections [6]. This observation also
suggests that dengue fever should be considered as a differential in
children presenting with febrile illnesses in this region. In addition,
public health measures aimed at the control of dengue also need to
consider the increasing number of affected children.
Most developing countries have epidemics of febrile illnesses
which can be confused with dengue fever [19]. A recent review of
15 published studies was unable to make any conclusions on the
signs and symptoms that can clinically distinguish dengue from
other febrile illnesses [20]. However, Srikiatkhacorn et. Al
reported a high specificity (99%) of the WHO criteria in a
prospective sample of dengue cases in Thailand [21]. The majority
of hospitalized patients in this study presented with nausea, rash
and myalgia in decreasing order of frequency. The reported
frequency of rash in dengue fever ranges from 50–66%[22].
Table 2. Characteristics of patients with dengue fever (DF)
and dengue hemorrhagic fever (DHF)- n(%).
Characteristic DF
1(%) DHF
1(%) N p-value
2
Demographics
Age (median 6
interquartile range)
26.0619.0 24.5618.0 201 0.905
Gender
Male 99(61.5) 30(75.0) 201 0.077
Female 62(38.5) 10(25.0)
Clinical Presentation
Fever 159/161(98.8) 39/39(100.0) 200 0.647
Nausea and/or
vomiting
93/161(57.8) 27/40(67.5) 201 0.173
Rash 44/161(27.3) 31/40(77.5) 201 ,0.001
Abdominal Pain 6/86(7.0) 1/11(9.1) 97 0.582
Diarrhea 26/161(16.2) 5/40(12.5) 201 0.384
Myalgia 46/161(28.6) 6/40(15.0) 201 0.056
Headache 21/161(13.0) 2/40(5.0) 201 0.120
Cough 22/161(13.7) 1/40(2.5) 201 0.033
Hemorrhage 6/161(3.7) 29/40(72.5) 201 ,0.001
Temperature (median) 38.0062 37.0061 177 0.014
Laboratory Findings
Thrombocytopenia at
presentation
116/151(76.8) 36/40(90.0) 191 0.047
Received platelet
transfusion
25/90(27.8) 13/32(40.6) 122 0.131
Low Hemoglobin 16/137(11.7) 8/37(21.6) 174 0.102
Hematocrit level on
admission (median)
39.5066.75 40.4068.80 167 0.607
Leukopenia 64/141(45.4) 9/37(24.3) 178 0.015
Neutropenia 35/133(26.3) 16/34(47.1) 167 0.018
Lymphocytosis 30/132(22.7) 7/33(21.2) 165 0.529
Monocytosis 32/122(26.2) 19/33(57.6) 155 0.001
Raised ALT 63/110(57.3) 27/32(84.4) 142 0.004
Raised AST 68/79(86.1) 25/26(96.2) 105 0.147
1Reported as number of individuals with finding/number of individuals in the
category. For example, diarrhea is reported as 26/161 under Dengue Fever
implying that 26 patients had diarrhea out of 161 total Dengue Fever patients.
DF – Dengue Fever, DHF – Dengue Hemorrhagic Fever.
2p-value was calculated using Mann-Whitney U test for age, temperature and
hematocrit. Chi-square/Fisher’s exact test were used for all other categorical
variables.
doi:10.1371/journal.pone.0012505.t002
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patients using a hand impression technique in a study conducted at
a teaching hospital in Sri Lanka [23]. In view of this, it is suggested
that evaluation of rash in patients presenting with short duration
fever may help in the diagnosis of dengue fever.
Most patients in this study had thrombocytopenia and deranged
liver enzymes at the time of admission. In addition, median ALT
levels were significantly higher in patients with DHF as compared
to those with DF and in adults as compared to children. Liver
injury is a common finding in dengue infections and it is mediated
by direct infection of hepatocytes and Kupffer cells [24,25].
Recently, Luiz et al suggested the use of markers such as ALT and
AST as parameters to evaluate severity in patients with dengue
fever [24]. Since grossly elevated liver enzymes are known to be an
early warning sign for severe disease and clinical bleeding,
vigorous follow up in such patients is warranted [25].
Early identification of patients with dengue at risk of developing
hemorrhage is an important clinical objective [20]. It was observed
that leukopenia was significantly more common in patients with
DF. On the other hand, raised neutrophil and monocyte counts
were more common in patients with DHF. Thus, total and
differential leukocyte count may be possible markers that
distinguish DF and DHF. However, additional prospective studies
are needed to establish an algorithm based on clinical and
laboratory features that can be validated and generalized to
identify individuals at risk of hemorrhage in the early stages of
illness.
Limitations of this study include its reliance on a convenience
sample from a laboratory serum bank for demographic data and
therefore, the proportion of dengue IgM positive patients may be
overestimated due to a selection bias. While the reported
proportions should not be mistaken for community prevalence of
dengue, this strategy remains appropriate for comparison of
demographic trends over the study period because sampling
conditions have not changed significantly over these years. In
addition, laboratory samples were received through a network of
125 collection points spread throughout the country. It may be
argued that awareness of the population regarding dengue
increased over the study period. However, it implies that an
increase in the total number of individuals tested each year would
be observed. No such trends of a yearly increase in total number of
individuals tested or proportion of dengue positive individuals was
observed and hence, increase in public awareness about dengue
does not seem to have influenced our results.
Conclusion
The results of this study describe the demographic trends of
dengue infections in Pakistan. Dengue virus is now endemic in the
country, circulating throughout the year with a peak incidence in
the post-monsoon period. Median age of dengue patients has
decreased and younger patients may have become more
susceptible. Total and differential leukocyte count may be useful
for identification of patients at risk of hemorrhage and their utility
needs to be studied further.
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